Needham & Company
-
CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
-
Needham & Company Reiterates Buy Rating, $20 PT on CorMedix (CRMD), Sees Latest Developments Removing Some Overhang
-
CorMedix (CRMD) PT Lowered to $29 at Needham & Company
-
CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference
-
Pre-Open Movers 10/16: (SEND) (TLRY) (RACE) Higher; (CRMD) (JELD) (GWW) Lower (more...)

